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Activation of procaspase-9 on the apoptosome is
a pivotal step in the intrinsic cell death pathway.
We now provide further evidence that caspase
recruitment domains of pc-9 and Apaf-1 form
a CARD-CARD disk that is flexibly tethered to the
apoptosome. In addition, a 3D reconstruction of the
pc-9 apoptosome was calculated without symmetry
restraints. In this structure, p20 and p10 catalytic
domains of a single pc-9 interact with nucleotide
binding domains of adjacent Apaf-1 subunits.
Together, disk assembly and pc-9 binding create
an asymmetric proteolysis machine. We also show
that CARD-p20 and p20-p10 linkers play important
roles in pc-9 activation. Based on the data, we
propose a proximity-induced association model for
pc-9 activation on the apoptosome. We also show
that pc-9 and caspase-3 have overlapping binding
sites on the central hub. These binding sites may
play a role in pc-3 activation and could allow the
formation of hybrid apoptosomes with pc-9 and
caspase-3 proteolytic activities.
INTRODUCTION
Programmed cell death terminates unwanted or dangerous cells
in higher organisms. This allows cellular constituents to be
recycled while avoiding inflammation (Danial and Korsmeyer,
2004; Green and Evan, 2002). In the intrinsic pathway, develop-
mental cues, DNA damage, growth factor withdrawal, or onco-
gene activation may act as signals to release cytochrome
c from mitochondria, through a pore complex in the outer
membrane (Moldoveanu et al., 2006; for review, see Riedl and
Shi, 2004). Cytochrome c binds to monomers of apoptotic
protease activating factor-1 (Apaf-1) to trigger a conformational
change that leads to nucleotide exchange and assembly of the
heptameric apoptosome (Zou et al., 1997, 1999, Liu et al.,
1996; for review, see Bratton and Salvesen, 2010).
Apaf-1 is a member of the AAA+ superfamily and contains
an N-terminal caspase recognition domain (CARD), a central1084 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd Anucleotide binding and oligomerization domain, and aC-terminal
regulatory region (Inohara and Nun˜ez, 2003; Danot et al., 2009).
During apoptosome assembly, nucleotide binding domains
(NBD) of seven Apaf-1 monomers associate to form an inner
ring within the central hub, while their helical (HD1) and winged
helix domains (WHD) form a second ring that encircles the
NBDs (Yuan et al., 2010). Helical domain 2 interacts with the
WHD in each subunit to form an extended arm and this feature
supports tandem b-propellers in the V-shaped regulatory region.
Cytochrome c is bound between the two b-propellers (Acehan
et al., 2002; Yu et al., 2005, Yuan et al., 2010) and serves as
the initial trigger for Apaf-1 assembly (Li et al., 1997; Hu et al.,
1999). Active site CARDs on Apaf-1 subunits appear to be flex-
ibly linked to their respective NBDs in the ground state apopto-
some (Yuan et al., 2010).
The holo-apoptosome directs apoptosis and is formed by
Apaf-1, cytochrome c, and procaspase-9 (pc-9) (Rodriguez
and Lazebnik, 1999; Zou et al., 1999; Hu et al., 1999; Srinivasula
et al., 1998). In this complex, Apaf-1 and pc-9 CARDs associate
to form a disk-like feature that sits above the central hub (Yuan
et al., 2010). The pc-9 apoptosome then activates executioner
procaspases, such as pc-3 and pc-7, by carrying out a limited
proteolysis that rearranges critical loops to form the active sites
(Shi, 2004; Riedl et al., 2001a, 2001b). Initiator procaspases such
as pc-9 are monomers in solution (Boatright et al., 2003, Chao
et al., 2005; Li and Yuan, 2008; Renatus et al., 2001), while
executioner caspases are constitutive dimers. Precise details
of pc-9 activation are not known but recent data supports a
proximity-induced dimerization model (Yin et al., 2006; Pop
et al., 2006; Boatright et al., 2003; Renatus et al., 2001).
However, pc-9 molecules that were re-engineered to form
constitutive dimers aremuch less active than pc-9 apoptosomes
(Chao et al., 2005). Hence, some interactions between pc-9
and the apoptosome may be required to activate the zymogen
(Chao et al., 2005; Yin et al., 2006).
In this paper, we provide additional evidence that pc-9 inter-
acts with Apaf-1 CARDs to form an activation disk. We then
systematically shortened the CARD-p20 linker and found that
the largest deletions significantly reduced pc-9 activation. We
surmise that the CARD-p20 linker may facilitate the binding of
pc-9 catalytic domains to the apoptosome. We localized this
binding site in a 3D map that was calculated without imposing
rotational symmetry. In the active apoptosome, the p20 and
p10 catalytic domains of a single pc-9 bind to neighboringll rights reserved
Figure 1. A CARD-CARD Disk Is Present on the Heptameric Apaf-1
Platform
(A) Eight representative class averages are shown of double apoptosomes.
The number of particles in each class is shown in the lower left corner of each
panel.
(B) Top views are shown of rotary metal shadowed, pc-9 CARD apoptosomes.
A strongly contrasted CARD-CARD disk is observed (white arrows).
(C) Top views are shown of ground state apoptosomes. White arrows indicate
weakly contrasted rings in some particles that may be due to Apaf-1 CARDs.
See also Figure S1.
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Activation of Procaspases on the Human ApoptosomeNBDs in the central hub, at a site adjacent to the CARD-CARD
disk. Thus, disk assembly and pc-9 binding work together to
create an asymmetric proteolysis machine. Based on the data,
we propose a model for pc-9 activation that requires prox-
imity-induced association of catalytic domains with the
apoptosome.
In the next step of the death pathway, pc-9 apoptosomes
cleavepc-3 to create hemiactive caspase-3/pc-3dimers and fully
active caspase-3 dimers. We confirmed that active caspase-3
binds to the pc-9 apoptosome (Bratton et al., 2001a; Hill et al.,
2004; Yin et al., 2006), while unprocessed pc-3 does not bindStructure 19, 1084–efficiently to the complex (Bratton et al., 2001a). Strikingly, cas-
pase-3 binding caused a dramatic loss of pc-9 activity because
these proteases have overlapping binding sites. We suggest
that hemiactive caspase-3/pc-3 dimers may bind transiently to
caspase-3 binding sites on the apoptosome, to increase the
probability of an activating cleavage in the remaining pc-3
subunit. In this scenario, hybrid apoptosomes may be formed
through feedbackbinding of caspase-3 dimers to the central hub.
RESULTS
A CARD-CARD disk on the pc-9 Apoptosome
We recently reported the structure of a human apoptosome with
bound pc-9 CARDs (Yuan et al., 2010). To prepare this complex,
we inserted a thrombin site in the linker between the CARD and
p20 domain of pc-9. We then engineered single and triple
mutants that removed known cleavage sites in the p20-p10 linker
to create pc-9t (D315A) andpc-9tm (E306A/D315A/D330A). After
assembling apoptosomes with pc-9tm, a single clip by thrombin
released the pc-9 catalytic domains (p20-p10) in low salt buffer
(LSB; Yuan et al., 2010). This created a pc-9 CARD apoptosome
that was less prone to aggregation than the pc-9 complex.
Procaspase-9 and Apaf-1 CARDs formed a disk-like feature
that sits above the heptameric platform in this complex (Yuan
et al., 2010) (see Figures S1AandS1Bavailable online). However,
the disk-like feature may be blurred because it is linked to the
platform by potentially flexible CARD-NBD linkers.
To further characterize the CARD-CARD disk and its role in
pc-9 activation, we determined the stoichiometry of pc-9 to
Apaf-1 in active apoptosomes with quantitative mass spectrom-
etry. In one experiment, apoptosomes were assembled with an
excess of pc-9 (D315A) molecules that contained a TEV site
within the CARD-p20 linker (pc-9TEV). Complexes were purified
on a 10%–40% glycerol gradient (Figure S2A, lane 8) and a peak
fraction was used to generate tryptic peptides, which were iden-
tified by tandem mass spectrometry (LC/MS-MS) (Experimental
Procedures). The peptide MS/MS total ion current (TIC) intensi-
ties from each protein were averaged together to estimate the
amount of each component in the complex (Asara et al., 2008;
Jiang et al., 2010). With this approach, the ratio of pc-9TEV to
Apaf-1 was found to be approximately 0.8: 1 (Figure S2C). As
a control, the observed ratio of Apaf-1 to cytochrome c was
approximately 1: 1.15 (Acehan et al., 2001). In a second experi-
ment, we used glycerol gradients to determine the amounts of
pc-9tm and cytochrome c that were just sufficient to saturate
binding to the apoptosome. Peak fractions of this complex are
shown in Figure S2B. We then assembled pc-9tm apoptosomes
and analyzed the complexes by quantitative mass spectrometry
(Figure S2C). The measured ratio for pc-9, Apaf-1, and
cytochrome c in the complexes was approximately 0.8: 1: 1.6.
Based on the data, we surmise that the apoptosome may bind
approximately five to seven pc-9 monomers to form the
CARD-CARD disk in the active complex.
We then analyzed approximately 1000 side views of double-
ring apoptosomes, which occurred at a frequency of approxi-
mately 2% in images of frozen-hydrated, pc-9 CARD apopto-
somes (Yuan et al., 2010). In total, 20 side-view classes
were obtained with EMAN (Ludtke et al., 1999) and 8 represen-
tative class averages are shown in Figure 1A. Two striking1096, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1085
Figure 2. Apaf-1 CARDs Are Flexibly Linked to the Central Hub in the Human Apoptosome
(A) A thrombin site was inserted into the CARD-NBD linker of Apaf-1 (marked with an asterisk) to create Apaf-1tb.
(B) Purified Apaf-1 with a thrombin site was assembled and run on a glycerol gradient. The gel profile shows that Apaf-1tb forms apoptosomes which run in
fractions 6–8, while excess cytochrome c remains in fractions 1–3.
(C) Thrombin cleavage of Apaf-1tb apoptosomes released CARDs, which stayed at the top (fractions 1–3), while the platform region migrated into the gradient
(fractions 9–12).
(D) Thrombin cleavage of the Apaf-1 monomer shows that the CARD-NBD linker is accessible.
(E) A molecular model is shown for flexibly tethered CARDs on the Apaf-1 platform and depicts the effects of thrombin.
See also Figure S2.
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Activation of Procaspases on the Human Apoptosomeobservations can be made from the classes. First, double-ring
particles are formed by interactions between CARD-CARD
disks, which are sandwiched between opposing platforms.
From the images, a single disk is estimated to be approxi-
mately 35–50 A˚ thick (depending upon the degree of interdigi-
tation). Second, the position of opposing platforms is quite
variable, as large lateral and vertical displacements are present.
This gives further support to our hypothesis that CARD-NBD
linkers of Apaf-1 molecules may act as flexible tethers for the
disk (Yuan et al., 2010).
To test the idea of a flexible tether, we created a mutant
Apaf-1 with a thrombin cleavage site inserted in the linker
between the CARD and helix a8 (Apaf-1tb; Figure 2A). Apopto-
somes were assembled with Apaf-1tb and their mobility on a
glycerol gradient was similar to wild-type complexes (Figure 2B,
lanes 6–8). When these complexes were treated with thrombin,
CARDs were released en masse and remained at the top of
the gradient (Figure 2C, lanes 1–3), while heptameric platforms
started to aggregate and ran in fractions 9–12 (Figure 2C).
These results are consistent with Apaf-1 CARDs being flexibly
arrayed on the apoptosome (Figure 2E), where they can interact
with pc-9 CARDs. In addition, the CARD-NBD linker is
disordered in the crystal structure of Apaf-1 (residues 1–591;
Riedl et al., 2005). Hence, it was not surprising that the
thrombin site in the linker is accessible in Apaf-1 monomers
(Figure 2D).1086 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd ATo estimate the size of the disk, we visualized pc-9 CARD
apoptosomes by rotary metal shadowing after freeze-fracture
and etching (Heuser, 1989) (Supplemental Experimental Proce-
dures). In top views, a strongly contrasted, disk-like feature is
visible above the platform (Figure 1B, white arrows). The disk
had a diameter of approximately 100 A˚ (after correcting for the
metal coating) and was present in most particles. We also
imaged ground state apoptosomes as a control. In these images,
we observed a weakly contrasted ring above the hepatmeric
platform. These rings (and partial rings) may represent flexibly
bound Apaf-1 CARDs that interact with each other to some
extent (Figure 1C, white arrows). Based on these studies, we
conclude that pc-9 and Apaf-1 CARDs form a novel disk that is
flexibly tethered to the central hub. Clearly, disk formation is
a key step in activation because it would concentrate pc-9 cata-
lytic domains in a region above the apoptosome to facilitate
zymogen activation.
Role of the CARD-p20 Linker in pc-9 Activation
Procaspase-9 has a potential linker of approximately 69
residues between the CARD and p20 domain, although the
actual linker may be comprised of the 49 residues inclusive of
Asn92-Gly140 (Figure 3A) (Renatus et al., 2001). In a recent
experiment, a 6 residue linker was sufficient to activate two
pc-9 catalytic domains attached to a GCN4 leucine zipper (Yin
et al., 2006). Hence, the function of the much longer linker inll rights reserved
Figure 3. The CARD-p20 Linker Plays a Critical role in pc-9 Activation
(A) A cartoon is shown of pc-9 domains and linkers. A thrombin site and various mutations are indicated on the expanded linker sequences.
(B) Proteolytic activities (rates) of various pc-9 mutants with D315A, either with or without the apoptosome, are shown as a histogram. Values for thrombin treated
samples are also shown. Error bars indicate the standard error for triplicate measurements.
(C) A histogram is shown of normalized proteolytic activity for pc-9 and pc-9D30L, without and with the apoptosome (blue and maroon bars, respectively).
(D) Time courses are shown for the proteolytic activity of mutant pc-9t apoptosomes in PB with pc-3 (C163A) as substrate. Proteolytic activity generates the p20
and p10 subunits of caspase-3.
(E) (left) Top and side views are shown of a surface-rendered 3D map from pc-9 CARD apoptosomes assembled with pc-9tD30L and treated with thrombin.
The CARD-CARD disk is shown in magenta and the platform is colored blue. (right) A side view is shown of the 3D map.
See also Figure S3.
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Activation of Procaspases on the Human Apoptosomepc-9 is mysterious. To study the role of the CARD-p20 linker, we
made a series of truncations that removed 7, 20, and 30 residues
directly downstream of an inserted thrombin site (Figure 3A).
When factoring in extra residues from the thrombin site, these
mutant procaspases have effective linker lengths of 1, 14,
and 24 residues relative to wild-type pc-9. A ribbon diagram
of the pc-9 dimer is shown in Figure S3 with CARD-p20 linkers
drawn roughly to scale for wild-type and D30L molecules. We
then measured the proteolytic activity of pc-9t linker mutants
with Ac-LEHD-AFC, in the presence and absence of the apopto-
some. For this experiment, we titrated the relative amount of
each protein to give a pc-9 to Apaf-1 ratio of approximately
1:1 (see glycerol gradients, Figure S4). Initial activity curves
derived from the fluorescent product were obtained for
complexes in a physiological buffer (PB) and in each case, we
also measured baseline activities after cutting the pc-9t linker
with thrombin to release the p20-p10 domains. Initial rates
were normalized to the activity of the pc-9t apoptosome (100)
and are plotted as a histogram in Figure 3B. These data provide
three important observations.
First, apoptosomes with pc-9t (+6 linker) showed a 50%
reduction in their activity relative to complexes made with
pc-9t D7L/-1. Thus, lengthening the wild-type linker can lower
activity. We suggest that the thrombin site may impair function
of the CARD-p20 linker, perhaps bymediating local aggregation,
which lowers activation by approximately 2.5-fold. Second,
proteolytic activity was maximal for pc-9t D7L/-1, which has
a linker that is nearly the same length as in wild-type pc-9. Third,
when the linker was shortened further (D20L/-14 and D30L/-24),
proteolytic activity of the complexes dropped dramatically
(approximately 4- and 9-fold, respectively). To show the gener-
ality of our results, we also tested the activity of apoptosomes
with wild-type pc-9 molecules that contained a D30L/-30
mutation in the CARD-p20 linker. These experiments were
done to eliminate possible side effects due to the thrombin site
in the CARD-p20 linker and due to the D315A mutation in the
p20-p10 linker. As shown in the next sections, each of these
mutations may affect the overall activity level of pc-9 on the
apoptosome. Based on fluorescence-based proteolysis assays,
we found a significant defect in pc-9D30L apoptosomes relative
to pc-9 complexes (Figure 3C). This shows that truncation of
the CARD-p20 linker to approximately 19 residues leads to a
significant loss of pc-9 activity on the apoptosome (approxi-
mately 80%).
Procaspase-9 apoptosomes cleave and activate pc-3. We
investigated this reaction using a pc-3 substrate in which the
active site residue (Cys163) was mutated to alanine, to prevent
self-cleavage during bacterial overexpression. In this experi-
ment, we used a 4-fold excess of pc-3 (C163A) relative to
pc-9t and carried out a 30 min time course at 37C for apopto-
somes with pc-9t and with each of the three linker mutants.
The cleavage of pc-3 to give p20 and p10 subunits was reduced
significantly with pc-9tD24L and D30L apoptosomes, relative to
complexes with pc-9t or pc-9tD7L (Figure 3D). In all cases, mock
reactions showed no pc-3 cleavage (not shown). In addition, the
overall activity level with pc-3 as a substrate paralleled the
activity of these complexes with a small polypeptide substrate.
We conclude that the defect in pc-9tD30L apoptosomes extends
to the proteolytic processing of pc-3. In addition, apoptosomes1088 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd Awith the pc-9tD7L mutant had the highest activity with either
substrate. Not unexpectedly, these experiments suggest that
the optimum linker length for activation is present in wild-type
pc-9 zymogens.
Next, we wondered if the activation defect in pc-9 molecules
with a truncated linker might arise from an inability to assemble
a CARD-CARD disk. To test this idea, we assembled apopto-
somes with pc-9tD30L and released the catalytic domains with
thrombin. We then froze these pc9 CARD apoptosomes, imaged
the complexes, and determined a structure at approximately
19 A˚ resolution with EMAN2 (Tang et al., 2007). A blurred disk
was present in the final, c7 symmetrized 3D map (Figure 3E),
which suggests that there is no gross defect in disk formation
with this mutant.
Role of the p20-p10 Linker
We observed a 25- to 30-fold activation of pc-9tD7L molecules
on the apoptosome relative to the complexes treated with
thrombin (Figure 3B). However, this value was lower than
expected (Shi, 2004). We reasoned that this may be due, in
part, to the D315A mutation in the p20-p10 linker. To test this
idea, we measured the proteolytic activities of apoptosomes
containing pc-9t with the D315A mutation and of complexes
without this mutation (pc-9t wt). In order to assess the effect of
the thrombin site, we also evaluated apoptosomes assembled
with pc-9 (D315A) or pc-9 (Figure 4A). In panels 1 and 3, the
D315A point mutation significantly reduced cleavage activity
toward pc-3, relative to complexes in panels 2 and 4 that con-
tained pc-9 molecules without this linker mutation. In addition,
time courses with wild-type pc9t and pc-9 showed extra density
on the gels at t = 0, due to the p35 and p10 subunits, which arise
from bacterial cleavage of the p20-p10 linker. These bands
overlapped the pc-3 and p10/cytochrome c bands, respectively
(Figure 4A). The relative effects of the D315A and thrombin site
mutants on pc-9 activation were also quantitated with the
fluorescence-based proteolysis assay, as discussed later (Fig-
ure 7F). We conclude that the D315A mutation in the p20-p10
linker has a significant effect on the final level of pc-9 activation
(see next section for a possible explanation).
Procaspase-9 Binding to the Apoptosome
To evaluate the possible role of pc-9 binding in activation, we
first compared the accessibility of the CARD-NBD linker in
apoptosomes assembled with Apaf-1tb that contained either
pc-9 or pc-9 (D315A). In this experiment, active complexes
were treated with thrombin and purified on glycerol gradients.
We found that clip sites in CARD-NBD linkers weremore strongly
protected when pc-9 was bound to the apoptosome (Figure 4B,
left), relative to complexes with pc-9 (D315A) (Figure 4B, right).
To more clearly visualize the protection, we probed the com-
plexes with thrombin and then visualized them directly on a gel
(Figure 4C). Since CARD-NBD linkers are located between the
disk and the platform, the protection experiments suggested
that pc-9 catalytic domains may bind to the apoptosome. If
this is the case, then wild-type catalytic domains of pc-9 may
bind with a higher affinity than domains containing the D315A
mutation.
Next, we asked if pc-9 catalytic domains could be visualized
on the apoptosome. We froze apoptosomes with wild-typell rights reserved
Figure 4. Properties of the pc-9 Apoptosome
(A) Time courses are shown for pc-3 cleavage by pc9 apoptosomes assembled with pc-9t (D315A), pc-9t wt, pc-9 (D315A), and pc-9 wt.
(B) Wild-type pc-9 molecules protect against thrombin cleavage in the CARD-NBD linker within Apaf-1tb apoptosomes. (Left) pc-9 apoptosomes were run on
a glycerol gradient after thrombinolysis. (Right) Apoptosomes with bound pc-9 (D315A) are not protected against thrombinolysis of the CARD-NBD linker.
(C) Complexes were probed directly with thrombin and the proteins were run on an 8% gel with SDS PAGE to enhance the resolution of the bands.
See also Figure S4.
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Activation of Procaspases on the Human Apoptosomepc-9 in LSB and determined a structure without symmetry
restraints, using approximately 20,000 particles and EMAN2
(Tang et al., 2007). To avoid bias, we startedwith an apoptosome
that did not contain the CARD-CARD disk. After refinement, the
3D map revealed the p20 and p10 catalytic domains of a single
pc-9 on the central hub, adjacent to the disk (Figures 5A–5D).
The FSC0.5 indicated a resolution of 16.9 A˚ and edge-view
classes revealed the disk and adjacent pc-9 density on the plat-
form (Figures S5A and S5B). Interestingly, helix a9 and strand b5
of an NBD are located in the ‘‘footprint’’ of the pc-9 catalytic
domain, along with the NBD-HD1 linker (Figure 5E). In addition,
bound pc-9 catalytic domains may also interact with helix a8 in
the NBD of an adjacent subunit. However, a gap is present
between the catalytic domains and the NBDs (see asterisk,
Figure 5E). This gap cannot be accounted for by the docked
models, which suggests that part of the CARD-p20 linker
may become ordered to help form the pc-9/NBD interface.
This may explain why pc-9 apoptosomes with a D30L deletion
in the zymogen are significantly less active than wild-type
complexes (Figure 3C).
The precision of our current docking is limited by the resolu-
tion. In this case, an unambiguous choice cannot be made
between the orientation in Figure 5E and a second position,
defined by a 180 degree rotation about the long axis of the
density. However, two aspects of pc-9 function aremore consis-
tent with the position shown in Figure 5E. First, the docking
explains why a D315A mutation in the p20-p10 linker of pc-9
may downregulate activation. In a pc-9 monomer, the uncleaved
p20-p10 linker may interfere with formation of the NBD interface,
because it would pass through the density footprint between the
two components (Figure S6 and Figure 5E, middle and right
panels). When Asp315 is cleaved, flexible L2 and L20 ends of
the p20-p10 linker may move laterally, allowing the catalytic
domains to interact more efficiently with the hub. The p20-p10
loop also backtracks from Asp315 into the active site where itStructure 19, 1084–anchors the catalytically active Cys285 (Figure S6, right). Thus,
changes in this region induced by binding and autoprocessing
of the p20-p10 loop could activate the pc-9 monomer. Second,
pc-9 is inhibited by the BIR3 domain of the X-inhibitor of
apoptosis (XIAP), which forms a complex with the N terminus
(L20) of the p10 subunit created by autoprocessing (Shiozaki
et al., 2003). In our model, the BIR3-p10 complex would block
activation by preventing the catalytic domains of pc-9 from
binding to the hub. A higher resolution 3D map will be required
to pin down the precise orientation of pc-9 catalytic domains
on the hub.
In our 3Dmap, the CARD-CARDdisk is located off-center rela-
tive to the central hub and appears to be tilted (Figures 5A–5D
and 6D). The acentric disk has apparent dimensions of approx-
imately 80 3 80 3 35 A˚ but the actual diameter of the disk as
determined from rotary metal shadowing is approximately
100 A˚ (see dashed circle in Figure 5A). This is consistent with
the idea that the disk is somewhat blurred in the 3Dmap because
of flexible CARD-NBD linkers (Yuan et al., 2010). We wondered if
the diskmay have been forced tomove off-center when the cata-
lytic domains of pc-9 are bound to the hub or alternatively,
whether the disk may assemble in an acentric position relative
to the hub. To evaluate these possibilities, we reprocessed
a large data set of pc-9 CARD apoptosomes from Yuan et al.
(2010) without symmetry restraints. These particles lack the
pc-9 catalytic domain, yet the disk in the resulting 3D map is
clearly acentric and tilted (Figures 6A–6C), as it is in pc-9
apoptosomes (Figures 5A–5D and 6D). Since the disk remains
in an acentric position after catalytic domains have been
released, it seems likely that coassembly of pc-9 and Apaf-1
CARDs may create a mismatch between the disk and central
hub. This also suggests that the disk itself may not have cylin-
drical symmetry.
In summary, the presence of amismatch between the disk and
central hub could pave the way for pc-9 catalytic domains to1096, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1089
Figure 5. Asymmetric Structure of the pc-9
Apoptosome
(A) A top view is shown of the pc-9 apoptosome
refined without symmetry restraints. A single copy
of the pc-9 catalytic domains (gold) is present on
the central hub. The platform is colored blue and
a dashed circle indicates the expected size of the
disk.
(B) The view in (A) is shown with a model of the
platform docked into a semitransparent surface
map. Note that the CARD-CARD disk (magenta) is
displaced laterally relative to NBDs (dark blue) in
the hub.
(C) A side view is shown of the pc-9 apoptosome
with the catalytic domains eclipsing the disk.
(D) A front view is shown with the complex rotated
approximately 77 from (C).
(E) Views from the top, inside surface and front
are shown of the pc-9 catalytic domains within a
transparent rendering of the map. The ‘‘inside’’
view shows the pc-9 catalytic domains as viewed
from the disk. A short ordered region of the
CARD-p20 linker is shown in pink. Unfilled density
is marked with an asterisk (*) and may represent
a region that is formed by the CARD-p20 linker,
which has not been modeled. The a80 helix
belongs to an adjacent NBD.
See also Figures S5 and S6.
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Activation of Procaspases on the Human Apoptosomebind to a single site on the hub. This may occur because the
acentric disk could block access to other binding sites, espe-
cially those on the far side of the hub relative to the observed
binding site (Figure 5). Since no additional density is present
on adjacent Apaf-1 subunits, it seems that catalytic domains of
only one pc-9 may be bound to this asymmetric proteolysis
machine. We also suspect that binding may be a dynamic
process with catalytic domains coming on and off the platform,
because a single clip with thrombin released all catalytic
domains from the pc-9t apoptosome, while the disk remained
intact (Yuan et al., 2010; see following section).
Caspase-3 Interactions with the Apoptosome
The mechanism of pc-3 activation by the pc-9 apoptosome is
not well understood. As a first step, we verified previous obser-
vations of caspase-3 binding to the apoptosome (Bratton et al.,
2001a; Hill et al., 2004; Yin et al., 2006;Malladi et al., 2009). In this
experiment, we added a 3- to 4-fold excess of unprocessed pc-3
(C163A) to pc-9t (D315A) apoptosomes in LSB and after 60 min
the cleavage reaction was treated with thrombin. Proteins were
then run on a glycerol gradient and visualized by SDS PAGE.
Significant amounts of caspase-3 comigrated with the pc-91090 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd All rights reservedCARD apoptosome, as shown by the
p20 subunit (note that the p10 subunit is
overlappedwith cytochrome c; Figure 7A,
lanes 8–11). Released pc-9 catalytic
domains, pc-3 and some caspase-3
stayed at the top of gradient. We then
confirmed that pc-3 does not bind to the
apoptosome. In this experiment, pc-9t
apoptosomes were treated with thrombinto release catalytic domains, unprocessed pc-3 (C163A) was
added for 60 min and the sample was run on a glycerol gradient.
Under these conditions, no proteolysis of pc-3 occurred and
most of the procaspase remained at the top of the gradient.
While there was some streaking of pc-3 aggregates into the
gradient (Figure 7B, lanes 1–5), these molecules were not asso-
ciated with pc-9 CARD apoptosomes, which peaked in fractions
6–8. Hence, unprocessed pc-3 does not bind strongly to the
apoptosome even though the zymogen is a constitutive dimer
like caspase-3. These results are in line with previous data
from Bratton et al. (2001a) in which cell lysates were supple-
mented with recombinant caspases. When taken together, the
data suggest that caspase-3 binding sites on the apoptosome
are able to discriminate between active and inactive conforma-
tions of the caspase. In addition, caspase-3 is able to cleave
Apaf-1 at Asp271 within the NBD (Bratton et al., 2001b). In our
apoptosome model, this cleavage site is buried within the inter-
face between adjoining Apaf-1 subunits and therefore is unlikely
to serve as a robust caspase-3 binding site (see Bratton et al.,
2001a; Hill et al., 2004; Yin et al., 2006).
We then investigated whether caspase-3 would compete
successfully with wild-type pc-9 for binding sites on the
Figure 6. Asymmetric Structure of the pc-9
CARD Apoptosome
(A) A top view is shown of the pc-9 CARD apop-
tosome. The acentric disk is shown inmagenta and
the platform region is rendered in blue. A dashed
circle shows the estimated diameter of the disk.
(B) A top view is shown of the asymmetric
reconstruction with a model of the platform region
docked into the density. The disk is located off-
center relative to the platform.
(C) A side view of the pc-9 CARD apoptosome
shows the tilted nature of the disk.
(D) For comparison, a similar view to panel C is
shown of the pc-9 apoptosome. The acentric disk
shows a similar tilt.
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wild-type pc-9t. These complexes were run on a glycerol
gradient or pretreated with thrombin before the gradient step.
In these experiments, wild-type pc-9 catalytic domains were
released from the apoptosome after thrombin treatment (Fig-
ure 7C, left and center panels). Hence, the affinity of wild-type
pc-9 catalytic domains for the apoptosome is greatly enhanced
by formation of the CARD-CARD disk. We then incubated pc-9t
wt apoptosomes with pc-3 (C163A) for 60 min, treated the
complexes with thrombin, and ran them on a glycerol gradient.
This created caspase-3/pc-9 CARD apoptosomes that migrated
into the gradient (Figure 7C, right panel), while released pc-9
catalytic domains remained at the top (not shown). Since
caspase-3 dimers remain bound to the apoptosome when
wild-type pc-9 catalytic domains are released by thrombin, the
data suggest that caspase-3 dimers are bound to the central
hub, rather than being bound by flexibly tethered catalytic
domains of pc-9.
To characterize these binding sites, we asked if pc-3 and
caspase-3 would protect a thrombin site in CARD-NBD linkers
of apoptosomes assembled with Apaf-1tb. We incubated pc-9
apoptosomes with pc-3 for either 10 or 60 min at 37C, before
thrombin addition. Complexes were then run on glycerol gradi-
ents and visualized by SDS PAGE. As expected, we found that
pc-3 did not protect the CARD-NBD linker from thrombin, since
the zymogen is not strongly bound (Figure 7D, top left; fractions
9–11). However, caspase-3 was able to protect the linker (Fig-
ure 7D, top right; fractions 6–8). We then compared the ability
of pc-9 and caspase-3 to protect CARD-NBD linkers in the apop-
tosome. For this experiment, we made appropriate complexes
and probed them directly with thrombin. The degree of linker
protectionwasmuch greater for caspase-3 than for pc-9 in these
complexes and CARD-NBD linkers were more protected than in
control apoptosomes (Figure 7D, bottom). When taken together,Structure 19, 1084–1096, August 10, 2011 ªthe data suggest that pc-9 and caspase-
3 may use overlapping binding sites on
the central hub, since they are both able
to protect the CARD-NBD linker.
We also asked if pc-9t apoptosomes
would proteolyze Ac-LEHD-AFC when
caspase-3wasbound. In this experiment,
we monitored pc-9 activity because cas-
pase-3 (C163A) is catalytically inactive.The activity of pc-9t apoptosomes was normalized to 100 (Fig-
ure 7E, left). When pc-3 was added at t = 0, the activity of pc-9t
apoptosomes was diminished by approximately 30%. Note
that the assay itself took approximately 15 min and some pc-3
was processed during this time. However, pc-9t activity in
the caspase-3 complexes was reduced nearly to background
levels when pc-3 was added 60 min before starting the assay
(compare Figures 7E and 7F, left set). We also tested the effect
of caspase-3 on apoptosomes with bound pc-9 molecules that
lacked the D315A mutation, including complexes with pc-9t wt
or pc-9 (Figure 7E, middle and right). In both cases, pc-9
molecules without the D315A mutation were significantly more
active than pc-9t (D315A) molecules (Figure 7F), as shown
previously (Figure 4). Cleavage of unprocessed pc-3 to
caspase-3 resulted in a dramatic loss of pc-9 activity to near
background levels in both cases (Figures 7E and 7F). Based on
our data, a possible explanation for these results is that pc-9
catalytic domains may be displaced from the central hub by
caspase-3. This leads to a loss of pc-9 activity while the catalytic
domains remain associated with the apoptosome through their
linkers to the stable CARD-CARD disk.
DISCUSSION
In this paper, we show that the activation of pc-9 on the apopto-
some involves the formation of a CARD-CARD disk and may
require direct binding of pc-9 catalytic domains to the central
hub. We also confirmed that caspase-3 binds to the apopto-
some, while unprocessed pc-3 does not bind efficiently. Unex-
pectedly, we found that caspase-3 and pc-9 have overlapping
binding sites on the apoptosome. This property allows cas-
pase-3 to downregulate pc-9 activity on the apoptosome by
feedback binding.When taken together, these data have allowed
us to propose models for the activation of pc-9 and pc-3.2011 Elsevier Ltd All rights reserved 1091
Figure 7. Activation of pc-3 on the Human Apoptosome
(A) Procaspase-3 (C163A) was added to pc-9t (D315A) apoptosomes and the cleavage reaction was continued for approximately 60 min. Complexes were then
treated with thrombin and run on a glycerol gradient. Activated caspase-3 is bound to pc-9 CARD apoptosomes, as shown by the p20 subunit in fractions 8–12.
The p10 subunit and cytochrome c overlap on this gel. Procaspase-3 and some active caspase-3 remained at the top, alongwith released pc-9 catalytic domains
(fractions 1–3).
(B) Procaspase-9t (D315A) apoptosomeswere treated with thrombin in LSB. Procaspase-3 (C163A) was then added for 60min and proteins were fractionated on
a glycerol gradient in PB. Unprocessed pc-3 dimers streaked into the gradient (fractions 1–6).
(C) (Left) Apoptosomeswith pc-9t wt were run on a glycerol gradient. Bacterially cleaved p35 subunits of pc-9, containing the CARD and p20 domain, comigrated
with the apoptosome. The p10 subunit overlaps cytochrome c on the gel. (Middle) Thrombin treatment of pc-9t wt apoptosomes released the catalytic domains.
(Right) Procaspase-3 was added to a similar pc-9t wt complex and treated with thrombin after a 60 min preincubation to release pc-9 catalytic domains. The
resulting caspase-3/pc-9 CARD apoptosomes peaked in fractions 8 and 9.
(D) Activated caspase-3 (C163A) protects pc-9 apoptosomes against thrombinolysis of a clip site in the CARD-NBD linker. (Top left) Preincubation for 10min does
not provide protection against cleavage. (Top right) Preincubation with pc-3 for 60min protects the CARD-p20 linker against thrombinolysis, due to the formation
of active caspase-3 dimers. (Bottom) pc-9 apoptosomes without and with pc-3 (60 min) were treated with thrombin and run at various loadings on the same 8%
gel with Apaf-1tb apoptosomes as a control.
(E) The proteolytic activity of pc-9 apoptosomes wasmeasured with Ac-LEHD-AFC and compared to complexes that contained pc-3 (C163A) added at time zero
or to complexes that were preincubated with pc-3 for 60 min. Three pc-9 zymogens were tested: left- pc9t (D315A), middle- pc-9t wt and right- pc-9. Error bars
indicate the standard error for three measurements.
(F) Controls were run for pc-9 apoptosome samples, including plus/minus apoptosomes and plus/minus thrombin, which cleaves the pc-9t linker releasing the
catalytic domains. left, pc9t (D315A); middle, pc-9t wt; and right, pc-9. The plots are normalized to 100 for pc-9t (D315A) apoptosomes.
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Figure 8. A Sequential Path for pc-9 and
pc-3 Activation on the Human Apoptosome
The Apaf-1 platform with bound cytochrome c is
shown in gray. Apaf-1 CARDs are colored light
green, the acentric CARD-CARD disk is colored in
magenta and subunits of pc-9 (gold) and pc-3
(blue) are color coded to indicate whether they are
active or inactive. For clarity, only five pc-9 mole-
cules are shown bound to the apoptosome. The
assembled disk is drawn to scale and is acentric
relative to the central hub, which may block some
pc-9 and caspase-3 binding sites. Binding sites for
caspase-3 are shown schematically.
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Apoptosome assembly requires cytochrome c binding and
nucleotide exchange (see Bratton and Salvesen, 2010 and Riedl
and Shi, 2004). During this process, each CARD is released
from its interactions with the NBD and WHD of Apaf-1. The
CARD-NBD linker is approximately 16 residues long and extends
from the CARD C terminus to the start of helix a8. This linker is
disordered in a crystal structure of Apaf1-591 that lacks the
regulatory region (Riedl et al., 2005). The CARD-NBD linker
may also be flexible in solution because a cleavage site inserted
within this feature is accessible to thrombin in the monomer.
Apaf-1 CARDs were completely disordered in our 3D map of
the ground state apoptosome (Yuan et al., 2010; Yu et al.,
2005). However, we could not rule out the possibility that CARDs
might have been disordered when exposed to the air water inter-
face during freezing. To test this idea, we showed that CARDs
are released en masse from apoptosomes assembled with
Apaf-1tb, when the linker is cut with thrombin. We conclude
that flexibly tethered CARDs are displayed on the top surface
of the ground state apoptosome in solution (Figure 8, panel 1).
Procaspase-9 Activation
In the first step of pc-9 activation, Apaf-1 CARDs interact with
pc-9 CARDs to form a tilted disk-like feature that is displaced
laterally on the central hub (Yuan et al., 2010; this work). This
assembly process concentrates pc-9 catalytic domains near
the apoptosome and primes them for activation. We suggest
that the diameter of the disk and its acentric position could limit
the number of possible binding sites for pc-9 catalytic domains
on the central hub (Figure 8, panel 2). This may explain why
catalytic domains of a single pc-9 are bound to the hub in
the active complex. In the extrinsic pathway, FAS and FADD
form a distorted disk comprised of five FAS and five FADD
Death Domains, arranged in roughly two layers (Wang et al.,
2010). CARDs are members of the Death Domain superfamily
and may form a related structure that does not follow the cylin-
drical symmetry of the apoptosome. This unusual architectureStructure 19, 1084–1096, August 10, 2011 ªmight also account for the tilted appear-
ance of the disk in our maps.
We now present a model of pc-9
activation on the apoptosome. Based
on our data, the apoptosome binds five
to seven pc-9 zymogens to assemble
a CARD-CARD disk and form an activecomplex. We suggest that pc-9 activation may occur by prox-
imity-induced association of catalytic domains with adjacent
NBDs in the central hub. Moreover, binding may be quite
dynamic with different copies of the tethered catalytic domains
being transiently activated as they bind to the central hub, after
bound catalytic domains have dissociated. These studies also
showed that pc-9 catalytic domains provide some protection
against thrombin cleavage of CARD-NBD linkers, which are
located between the disk and central hub. Conversely, pc-9
(D315A) did not protect CARD-NBD linkers, presumably
because catalytic domains of themutant do not bind as strongly.
To account for the observed level of protection by wild-type
pc-9, we suggest that the acentric disk may protect three to
four CARD-NBD linkers of Apaf-1, while the disk also blocks
access to additional binding sites on the hub. Hence, the
holo-apoptosome may contain a single active pc-9 (Figure 8,
panel 2).
We also found that pc-9 activation requires an optimal length
for the CARD-p20 linker because truncations in this loop resulted
in a significant loss of activity. We suggest that the first approx-
imately 20 residues of the CARD-p20 linker may act as a spacer
to facilitate the binding of catalytic domains to the central hub,
while the C-terminal region of the linker may help form the inter-
face between p20-p10 domains and adjacent NBDs. This would
explain why pc-9 activation is greatly reduced in our linker trun-
cation mutants. In addition, the CARD-p20 linker may serve as
a flexible tether for inactive pc-9 catalytic domains that are
bound to the disk (Figure 8, panel 2). We also found a 50%
loss in pc-9 activation when a 6 residue thrombin site was
inserted into the CARD-p20 linker. We speculate that the
thrombin site may lead to local effects, such as transient aggre-
gation of the linkers, which impede activation.
The p20-p10 linker of pc-9 is much longer than in other pro-
caspases and may play a role in activation. Cleavage of this
‘‘activation loop’’ was initially thought to be required for activity
(Thornberry and Lazebnik, 1998), but subsequent studies
showed that uncleaved pc-9 is activated on the apoptosome,2011 Elsevier Ltd All rights reserved 1093
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2010). We found that the activity of pc-9t (D315A) with an un-
cleaved p20-p10 linker is diminished by approximately 2-fold,
relative to processed pc-9t wt. This activity loss is correlated
with a weaker protection of CARD-NBD linkers in the apopto-
some by pc-9 (D315A), relative to pc-9. One could argue that
an intact p20-p10 linker may impede pc-9 dimerization due to
its proximity, even though the loop itself is not in the interface
(Renatus et al., 2001). However, our data suggest that an intact
p20-p10 loop may interfere with the binding of pc-9 catalytic
domains to the apoptosome. This would lower the efficiency of
zymogen activation and may explain why the p20-p10 linker of
pc-9 undergoes autoprocessing.
A generally acceptedmodel for pc-9 activation is based on the
idea that local proximity may promote pc-9 dimerization, which
in turn triggers activation (Yin et al., 2006; Pop et al., 2006; Boat-
right et al., 2003; Renatus et al., 2001). In particular, pc-9 cata-
lytic domains were fused to the GCN leucine zipper with a 6
residue linker and these zymogens were activated, presumably
by dimerization (Yin et al., 2006). Conceptually, it is easy to
understand why a short linker may activate pc-9 by dimerization
because CARD-less pc-9 molecules crystallize as a hemiactive
dimer at high protein concentration (Renatus et al., 2001).
Contrary to our expectations, we found that proteolytic activity
on the apoptosome was significantly reduced in pc-9 zymogens
with a 30 residue deletion in the CARD-p20 linker. These pc-9
molecules retained 19 residues between the CARD and
Gly140. We reasoned that this greatly shortened linker should
have been sufficient to promote activation of adjacent pc-9
molecules tethered to the disk, if dimerization were the preferred
mechanism.
In a second elegant study, a pc-9 CARD and its linker (residues
1–152) were coupled to pc-8 catalytic domains and this chimeric
molecule was activated on the apoptosome (Pop et al., 2006). In
this experiment, activation may have been due to the similar
tertiary structures of pc-8 and pc-9 catalytic domains, CARD-
CARD interactions between the chimeric zymogen and Apaf-1,
and the presence of the entire CARD-p20 linker of pc-9 at
the appropriate position in this molecule. In our structure of the
pc-9 apoptosome, the CARD-p20 linker may form part of
the NBD/catalytic domain interface. Hence, the CARD-p20 linker
may have helped to activate catalytic domains in chimeric pc-9/
pc-8 molecules, by promoting binding to the central hub. In
contrast, a second activation model has been proposed in which
local binding of pc-9 catalytic domains to the apoptosomewould
activate the zymogen (Chao et al., 2005; Yin et al., 2006). Data
presented in this paper suggest that aspects of both models
are correct.
We propose that pc-9 activation occurs through proximity-
induced association. In the first step, a CARD-CARD disk is
formed by pc-9 and Apaf-1 CARDs. During assembly the disk
adopts an off-center position relative to the hub. We speculate
that the acentric disk may block access to potential binding
sites on the hub, leaving only one available binding site for
pc-9 catalytic domains (Figure 8, panel 2). In the second step,
pc-9 catalytic domains bind to the hub and are activated by
conformational changes of appropriate loops in the zymogen.
This activation step may be facilitated by autoprocessing of
the p20-p10 loop.1094 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd AProcaspase-3 Activation
Caspase-3 associates with apoptosomes in lysates from
apoptotic cells (Bratton et al., 2001a; Hill et al., 2004) and also
forms a complex with the apoptosome when using purified
proteins (Yin et al., 2006). In addition, the apparent Km of pc-9
apoptosomes for their pc-3 substrate is much lower than for
pc-9 catalytic domains attached to a leucine zipper. This
suggested that pc-3 activation may require transient binding to
uncharacterized sites on the apoptosome (Yin et al., 2006). In
extending these studies, we verified that uncleaved pc-3 does
not bind efficiently to the apoptosome (Bratton et al., 2001a).
We also confirmed that pc-3 molecules which have been
processed by the pc-9 apoptosome are able to bind robustly
to this complex (this work, Yin et al., 2006 Bratton et al.,
2001a, Malladi et al., 2009). Hence, this binding site is able to
discriminate between inactive pc-3 and active caspase-3.
Strikingly, we found that caspase-3 inhibits pc-9 activity.
When taken together, our data suggest that caspase-3 dimers
may dislodge pc-9 catalytic domains from the central hub
(Figure 8, panels 4 and 5). This may occur because pc-9 and
caspase-3 have overlapping binding sites, as suggested by
protection of the CARD-NBD linker of Apaf-1 from thrombin
cleavage. In this model, pc-9 catalytic domains remain tethered
to the disk by their CARD-p20 linker but are inactive. When
combined with structural data on the pc-9 apoptosome, this
argues that bound catalytic domains of pc-9 are active. We
also note that an asymmetric apoptosome with bound pc-9
catalytic domains would serve no obvious purpose, if dimers
of flexibly attached pc-9 catalytic domains were the active
species.
The observation of a specific and robust binding site for cas-
pase-3 dimers further suggests that hemiactivated caspase-3/
pc-3 dimers could bind to the platform by their activated
subunits (Figure 8, panel 3). This would keep hemiactivated
caspase-3/pc-3 dimers near the apoptosome, thereby im-
proving the probability of a second cleavage in the remaining
pc-3 subunit when it dissociates (for simplicity, we are ignoring
clips that remove the N-terminal prodomains). Finally, why is
there a mismatch between the disk and platform? The active
apoptosome may provide multiple binding sites for caspase-3
dimers on the central hub, even though catalytic domains of
a single pc-9 are bound (Figure 8, panel 2). In this scenario,
the apoptosome could bind hemiactivated caspase-3/pc-3
dimers at adjacent sites that are not sterically blocked by the
disk or by bound pc-9 catalytic domains, without losing pc-9
activity. Since intracellular concentrations of pc-9 and pc-3
are approximately 10 and 20 nM, respectively (Kim et al.,
2008; Stoka et al., 2001), the initiator apoptosome would acti-
vate pc-3 in an efficient manner. However, in some cells the
pc-3 concentration has been estimated to be as high as
approximately 100 nM (Yin et al., 2006). In this case, feedback
binding could create a wheel of death with caspase-3 dimers
and pc-9 forming a hybrid complex (Figure 8, panel 4; Bratton
et al., 2001a; Malladi et al., 2009). If sufficiently high concentra-
tions of caspase-3 are present, then an executioner apopto-
some could be formed (Figure 8, panel 5) that is in equilibrium
with free caspase-3 dimers. Additional studies are now needed
to probe the structure and function of pc-9 and caspase-3 on
the apoptosome.ll rights reserved
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The preparation of pc-9 and Apaf-1 mutants and other experimental methods,
including glycerol gradients, pc-9 activity assays, quantitativemass spectrom-
etry and metal shadowing of the complexes, are described in Supplemental
Experimental Procedures. Procaspase-9 apoptosomes were prepared for
electron cryo-microscopy as described (Yuan et al., 2010) with somemodifica-
tions and data were collected on a TF20 microscope at 120 kV with a 4kx4k
CCD (TVIPS). Image processing was done with EMAN2 and EMAN1 (Tang
et al., 2007). The resolution of asymmetric pc-9 apoptosome and pc-9
CARD apoptosome maps was determined to be 16.9 and 11 A˚, respectively.
Both maps were filtered to approximately 17 A˚ resolution to provide an optimal
view of the acentric disk. All crystal structures and models were docked into
density maps with chimera (Goddard et al., 2005) and the catalytic domains
of pc-9 were manually adjusted in the density.ACCESSION NUMBERS
A 3D density map of the pc-9 apoptosome has been deposited to the EMDB
(EMD-1931).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at doi:10.1016/j.str.
2011.07.001.
ACKNOWLEDGMENTS
We thank Guy Salvesen and Yigong Shi for providing pc-3(C163A) and
pc-9 expression clones, respectively. We also thank Fenghe Du and X.
Wang for sf21 insect cells and helpful discussions on Apaf-1 expression and
purification. The Ludtke lab was supported by NIH grants R01GM080139
and P41RR02250. The Akey laboratory was supported by an NIH grant (RO1
GM63834).
Received: April 14, 2011
Revised: June 12, 2011
Accepted: June 23, 2011
Published: August 9, 2011
REFERENCES
Acehan, D., Jiang, X., Morgan, D.G., Heuser, J.E., Wang, X., and Akey, C.W.
(2002). Three-dimensional structure of the apoptosome: implications for
assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423–432.
Asara, J.M., Christofk, H.R., Freimark, L.M., and Cantley, L.C. (2008). A label-
free quantification method by MS/MS TIC compared to SILAC and spectral
counting in a proteomics screen. Proteomics 8, 994–999.
Bratton, S.B., and Salvesen, G.S. (2010). Regulation of the Apaf-1-caspase-9
apoptosome. J. Cell Sci. 123, 3209–3214.
Bratton, S.B., Walker, G., Srinivasula, S.M., Sun, X.M., Butterworth, M.,
Alnemri, E.S., and Cohen, G.M. (2001a). Recruitment, activation and retention
of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes.
EMBO J. 20, 998–1009.
Bratton, S.B., Walker, G., Roberts, D.L., Cain, K., and Cohen, G.M. (2001b).
Caspase-3 cleaves Apaf-1 into an approximately 30 kDa fragment that
associates with an inappropriately oligomerized and biologically inactive
approximately 1.4 MDa apoptosome complex. Cell Death Differ. 8, 425–433.
Boatright, K.M., Renatus, M., Scott, F.L., Sperandio, S., Shin, H., Pedersen,
I.M., Ricci, J.E., Edris, W.A., Sutherlin, D.P., Green, D.R., and Salvesen, G.S.
(2003). A unified model for apical caspase activation. Mol. Cell 11, 529–541.
Chao, Y., Shiozaki, E.N., Srinivasula, S.M., Rigotti, D.J., Fairman, R., and Shi,
Y. (2005). Engineering a dimeric caspase-9: a re-evaluation of the induced
proximity model for caspase activation. PLoS Biol. 3, e183.Structure 19, 1084–Danial, N.N., and Korsmeyer, S.J. (2004). Cell death: critical control points. Cell
116, 205–219.
Danot, O., Marquenet, E., Vidal-Ingigliardi, D., and Richet, E. (2009). Wheel of
life, wheel of death: a mechanistic insight into signaling by STAND proteins.
Structure 17, 172–182.
Goddard, T.D., Huang, C.C., and Ferrin, T.E. (2005). Software extensions to
UCSF chimera for interactive visualization of large molecular assemblies.
Structure 13, 473–482.
Green, D.R., and Evan, G.I. (2002). A matter of life and death. Cancer Cell 1,
19–30.
Heuser, J. (1989). Protocol for 3-D visualization of molecules on mica via the
quick-freeze, deep-etch technique. J. Electron Microsc. Tech. 13, 244–263.
Hill, M.M., Adrain, C., Duriez, P.J., Creagh, E.M., and Martin, S.J. (2004).
Analysis of the composition, assembly kinetics and activity of native Apaf-1
apoptosomes. EMBO J. 23, 2134–2145.
Hu, Y., Benedict, M.A., Ding, L., and Nu´n˜ez, G. (1999). Role of cytochrome c
and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and
apoptosis. EMBO J. 18, 3586–3595.
Inohara, N., and Nun˜ez, G. (2003). NODs: intracellular proteins involved in
inflammation and apoptosis. Nat. Rev. Immunol. 3, 371–382.
Jiang, X., Chen, S., Asara, J.M., and Balk, S.P. (2010). Phosphoinositide
3-kinase pathway activation in phosphate and tensin homolog (PTEN)-defi-
cient prostate cancer cells is independent of receptor tyrosine kinases and
mediated by the p110beta and p110delta catalytic subunits. J. Biol. Chem.
285, 14980–14989.
Kim, H.E., Jiang, X., Du, F., and Wang, X. (2008). PHAPI, CAS, and Hsp70
promote apoptosome formation by preventing Apaf-1 aggregation and
enhancing nucleotide exchange on Apaf-1. Mol. Cell 30, 239–247.
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S.,
andWang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/
caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489.
Liu, X., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of
apoptotic program in cell-free extracts: requirement for dATP and cytochrome
c. Cell 86, 147–157.
Ludtke, S.J., Baldwin, P.R., and Chiu, W. (1999). EMAN: semiautomated soft-
ware for high-resolution single-particle reconstructions. J. Struct. Biol. 128,
82–97.
Malladi, S., Challa-Malladi, M., Fearnhead, H.O., and Bratton, S.B. (2009). The
Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based
molecular timer. EMBO J. 28, 1916–1925.
Moldoveanu, T., Liu, Q., Tocilj, A., Watson, M., Shore, G., and Gehring, K.
(2006). The X-ray structure of a BAK homodimer reveals an inhibitory zinc
binding site. Mol. Cell 24, 677–688.
Pop, C., Timmer, J., Sperandio, S., and Salvesen, G.S. (2006). The apopto-
some activates caspase-9 by dimerization. Mol. Cell 22, 269–275.
Renatus, M., Stennicke, H.R., Scott, F.L., Liddington, R.C., and Salvesen, G.S.
(2001). Dimer formation drives the activation of the cell death protease cas-
pase 9. Proc. Natl. Acad. Sci. USA 98, 14250–14255.
Riedl, S.J., and Shi, Y. (2004). Molecular mechanisms of caspase regulation
during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897–907.
Riedl, S.J., Fuentes-Prior, P., Renatus, M., Kairies, N., Krapp, S., Huber, R.,
Salvesen, G.S., and Bode, W. (2001a). Structural basis for the activation of
human procaspase-7. Proc. Natl. Acad. Sci. USA 98, 14790–14795.
Riedl, S.J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S.W.,
Liddington, R.C., and Salvesen, G.S. (2001b). Structural basis for the inhibition
of caspase-3 by XIAP. Cell 104, 791–800.
Riedl, S.J., Li, W., Chao, Y., Schwarzenbacher, R., and Shi, Y. (2005). Structure
of the apoptotic protease-activating factor 1 bound to ADP. Nature 434,
926–933.
Rodriguez, J., and Lazebnik, Y. (1999). Caspase-9 and APAF-1 form an active
holoenzyme. Genes Dev. 13, 3179–3184.
Stoka, V., Turk, B., Schendel, S.L., Kim, T.H., Cirman, T., Snipas, S.J., Ellerby,
L.M., Bredesen, D., Freeze, H., Abrahamson, M., et al. (2001). Lysosomal1096, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1095
Structure
Activation of Procaspases on the Human Apoptosomeprotease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the
most likely route. J. Biol. Chem. 276, 3149–3157.
Shi, Y. (2004). Caspase activation: revisiting the induced proximity model. Cell
117, 855–858.
Shiozaki, E.N., Chai, J., Rigotti, D.J., Riedl, S.J., Li, P., Srinivasula, S.M.,
Alnemri, E.S., Fairman, R., and Shi, Y. (2003). Mechanism of XIAP-mediated
inhibition of caspase-9. Mol. Cell 11, 519–527.
Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E.S. (1998).
Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell
1, 949–957.
Tang, G., Peng, L., Baldwin, P.R., Mann, D.S., Jiang, W., Rees, I., and Ludtke,
S.J. (2007). EMAN2: an extensible image processing suite for electron micros-
copy. J. Struct. Biol. 157, 38–46.
Thornberry, N.A., and Lazebnik, Y. (1998). Caspases: enemies within. Science
281, 1312–1316.
Wang, L., Yang, J.K., Kabaleeswaran, V., Rice, A.J., Cruz, A.C., Park, A.Y., Yin,
Q., Damko, E., Jang, S.B., Raunser, S., et al. (2010). The Fas-FADD death1096 Structure 19, 1084–1096, August 10, 2011 ª2011 Elsevier Ltd Adomain complex structure reveals the basis of DISC assembly and disease
mutations. Nat. Struct. Mol. Biol. 17, 1324–1329.
Yin, Q., Park, H.H., Chung, J.Y., Lin, S.C., Lo, Y.C., da Graca, L.S., Jiang, X.,
and Wu, H. (2006). Caspase-9 holoenzyme is a specific and optimal procas-
pase-3 processing machine. Mol. Cell 22, 259–268.
Yu, X., Acehan, D., Me´ne´tret, J.F., Booth, C.R., Ludtke, S.J., Riedl, S.J., Shi, Y.,
Wang, X., and Akey, C.W. (2005). A structure of the human apoptosome at
12.8 A resolution provides insights into this cell death platform. Structure 13,
1725–1735.
Yuan, S., Yu, X., Topf, M., Ludtke, S.J., Wang, X., and Akey, C.W. (2010).
Structure of an apoptosome-procaspase-9 CARD complex. Structure 18,
571–583.
Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. (1997). Apaf-1,
a human protein homologous to C. elegans CED-4, participates in cytochrome
c-dependent activation of caspase-3. Cell 90, 405–413.
Zou, H., Li, Y., Liu, X., and Wang, X. (1999). An APAF-1.cytochrome c multi-
meric complex is a functional apoptosome that activates procaspase-9.
J. Biol. Chem. 274, 11549–11556.ll rights reserved
